- Home
- MYPS vs STRO Comparison
MYPS vs STRO Comparison
Compare MYPS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYPS
- STRO
- Stock Information
- Founded
- MYPS 2011
- STRO 2003
- Country
- MYPS United States
- STRO United States
- Employees
- MYPS N/A
- STRO N/A
- Industry
- MYPS EDP Services
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MYPS Technology
- STRO Health Care
- Exchange
- MYPS Nasdaq
- STRO Nasdaq
- Market Cap
- MYPS 192.0M
- STRO 377.0M
- IPO Year
- MYPS N/A
- STRO 2018
- Fundamental
- Price
- MYPS $1.46
- STRO $4.12
- Analyst Decision
- MYPS Buy
- STRO Strong Buy
- Analyst Count
- MYPS 4
- STRO 8
- Target Price
- MYPS $3.33
- STRO $12.13
- AVG Volume (30 Days)
- MYPS 198.2K
- STRO 614.7K
- Earning Date
- MYPS 10-31-2024
- STRO 08-13-2024
- Dividend Yield
- MYPS N/A
- STRO N/A
- EPS Growth
- MYPS N/A
- STRO N/A
- EPS
- MYPS N/A
- STRO N/A
- Revenue
- MYPS $303,388,000.00
- STRO $169,359,000.00
- Revenue This Year
- MYPS N/A
- STRO N/A
- Revenue Next Year
- MYPS $3.21
- STRO N/A
- P/E Ratio
- MYPS N/A
- STRO N/A
- Revenue Growth
- MYPS N/A
- STRO 197.83
- 52 Week Low
- MYPS $1.44
- STRO $2.01
- 52 Week High
- MYPS $3.49
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- MYPS 36.12
- STRO 47.64
- Support Level
- MYPS $1.46
- STRO $4.43
- Resistance Level
- MYPS $1.52
- STRO $4.45
- Average True Range (ATR)
- MYPS 0.06
- STRO 0.34
- MACD
- MYPS 0.01
- STRO -0.06
- Stochastic Oscillator
- MYPS 4.76
- STRO 11.02
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore, and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.